The following video is part of our "Motley Fool Conversations" series, in which Motley Fool technology editor Andre w Tonner and consumer goods editor Austin Smith discuss their favorite stocks.
In today's edition, Andrew and Austin talk about one dividend stock they'd buy, and one they'd sell going into the New Year. As many people make resolutions to get in shape, eat healthier, and be nicer, they often forget that their portfolios could probably use a similar realignment. Don't overlook this company to buy, or fool yourself into thinking the one company to sell has a secretly bright future.
Austin Smith owns shares of Pfizer. Andrew Tonner own no shares of the companies listed above. The Motley Fool owns shares of Johnson & Johnson. Motley Fool newsletter services have recommended buying shares of Johnson & Johnson and Pfizer, as well as creating a diagonal call position in Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.